Skip to main content
. 2021 Sep 17;13(9):1496. doi: 10.3390/pharmaceutics13091496

Figure 3.

Figure 3

Alterations of 15 ginsenosides following the incubation of RGE with LAB for 7 days were expressed as the relative percentage of ginsenoside on the first day. (A) PPD-type ginsenosides except for final metabolite PPD; (B) PPT-type ginsenosides except for final metabolite PPT; (C) final metabolite ginsenosides PPD and PPT; (D) Optical density at 600 nm (OD600) of the MRS broth incubating RGE with LAB for 7 days. Data point represents the mean ± standard deviation (n = 3).